HRP20110712T1 - Novi postupak za dobivanje kristalnog oblika agomelatina - Google Patents

Novi postupak za dobivanje kristalnog oblika agomelatina Download PDF

Info

Publication number
HRP20110712T1
HRP20110712T1 HR20110712T HRP20110712T HRP20110712T1 HR P20110712 T1 HRP20110712 T1 HR P20110712T1 HR 20110712 T HR20110712 T HR 20110712T HR P20110712 T HRP20110712 T HR P20110712T HR P20110712 T1 HRP20110712 T1 HR P20110712T1
Authority
HR
Croatia
Prior art keywords
crystalline form
agomelatine
formula
compound
accordance
Prior art date
Application number
HR20110712T
Other languages
English (en)
Croatian (hr)
Inventor
Martins Damien
Coquerel G�rard
Linol Julie
Langlois Pascal
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40418877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110712(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20110712T1 publication Critical patent/HRP20110712T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
HR20110712T 2008-08-05 2011-10-05 Novi postupak za dobivanje kristalnog oblika agomelatina HRP20110712T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804466A FR2934856B1 (fr) 2008-08-05 2008-08-05 Nouveau procede d'obtention de la forme cristalline v de l'agomelatine

Publications (1)

Publication Number Publication Date
HRP20110712T1 true HRP20110712T1 (hr) 2011-11-30

Family

ID=40418877

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110712T HRP20110712T1 (hr) 2008-08-05 2011-10-05 Novi postupak za dobivanje kristalnog oblika agomelatina

Country Status (46)

Country Link
US (1) US8252957B2 (sl)
EP (1) EP2151430B1 (sl)
JP (1) JP5047240B2 (sl)
KR (1) KR101118335B1 (sl)
CN (1) CN101643432B (sl)
AP (1) AP3196A (sl)
AR (1) AR074889A1 (sl)
AT (1) ATE518825T1 (sl)
AU (1) AU2009203071B2 (sl)
BR (1) BRPI0903058A2 (sl)
CA (1) CA2674770C (sl)
CL (1) CL2009001685A1 (sl)
CO (1) CO6120151A1 (sl)
CR (1) CR10952A (sl)
CY (1) CY1111873T1 (sl)
DK (1) DK2151430T3 (sl)
EA (1) EA016896B1 (sl)
EC (1) ECSP099554A (sl)
ES (1) ES2371047T3 (sl)
FR (1) FR2934856B1 (sl)
GE (1) GEP20125408B (sl)
GT (1) GT200900215A (sl)
HK (1) HK1141005A1 (sl)
HN (1) HN2009001437A (sl)
HR (1) HRP20110712T1 (sl)
IL (1) IL200126A (sl)
JO (1) JO2812B1 (sl)
MA (1) MA31223B1 (sl)
ME (1) ME00929B (sl)
MX (1) MX2009008046A (sl)
MY (1) MY151042A (sl)
NI (1) NI200900154A (sl)
NZ (1) NZ578826A (sl)
PE (1) PE20100153A1 (sl)
PL (1) PL2151430T3 (sl)
PT (1) PT2151430E (sl)
RS (1) RS52002B (sl)
SA (1) SA109300499B1 (sl)
SG (1) SG158830A1 (sl)
SI (1) SI2151430T1 (sl)
SV (1) SV2009003345A (sl)
TW (1) TW201008901A (sl)
UA (1) UA102816C2 (sl)
UY (1) UY32014A (sl)
WO (1) WO2010015747A1 (sl)
ZA (1) ZA200905334B (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101781226B (zh) * 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
WO2012093402A1 (en) * 2011-01-04 2012-07-12 Symed Labs Limited Processes for the preparation of n-[2-(7-methoxy-1-naphthyl)ethyl]acetamide
WO2012130837A1 (en) 2011-03-28 2012-10-04 Ratiopharm Gmbh Solid agomelatine in non-crystalline form
EP2872129B1 (en) 2012-07-16 2017-03-08 ratiopharm GmbH Complex of agomelatine and cyclodextrin
WO2015124496A1 (en) 2014-02-19 2015-08-27 Synthon B.V. Pharmaceutical composition comprising amorphous agomelatine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1703641A1 (ru) * 1988-02-23 1992-01-07 Ростовский государственный университет Способ получени 3,5-ди-трет.бутил-4-оксиацетанилида
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
YU48420B (sh) * 1991-03-25 1998-07-10 Hoechst Aktiengesellschaft Postupak za dobijanje biološki razgradljivih mikročestica sa dugotrajnim delovanjem
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2889521B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889522B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iv de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889523B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
WO2008141033A1 (en) * 2007-05-08 2008-11-20 Auspex Pharmaceuticals Inc. Substituted naphthalenes
FR2923482B1 (fr) * 2007-11-09 2010-01-29 Servier Lab Nouvelle forme cristalline vi de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
EP2151430B1 (fr) 2011-08-03
TW201008901A (en) 2010-03-01
NZ578826A (en) 2010-11-26
IL200126A (en) 2013-04-30
CN101643432B (zh) 2012-12-12
DK2151430T3 (da) 2011-11-21
KR101118335B1 (ko) 2012-03-09
SI2151430T1 (sl) 2011-10-28
IL200126A0 (en) 2010-05-31
PE20100153A1 (es) 2010-03-06
FR2934856A1 (fr) 2010-02-12
CA2674770A1 (fr) 2010-02-05
EP2151430A1 (fr) 2010-02-10
US8252957B2 (en) 2012-08-28
MA31223B1 (fr) 2010-03-01
CO6120151A1 (es) 2010-01-29
MY151042A (en) 2014-03-31
MX2009008046A (es) 2010-03-23
CR10952A (es) 2009-10-15
CL2009001685A1 (es) 2010-07-19
AP2009004936A0 (en) 2009-08-31
ATE518825T1 (de) 2011-08-15
RS52002B (en) 2012-04-30
BRPI0903058A2 (pt) 2010-05-25
AR074889A1 (es) 2011-02-23
ECSP099554A (es) 2010-03-31
FR2934856B1 (fr) 2010-08-13
US20100036165A1 (en) 2010-02-11
SV2009003345A (es) 2010-02-01
AU2009203071B2 (en) 2013-10-31
EA200900944A1 (ru) 2010-04-30
GEP20125408B (en) 2012-02-27
SA109300499B1 (ar) 2013-10-06
GT200900215A (es) 2011-07-19
ZA200905334B (en) 2010-05-26
HN2009001437A (es) 2011-09-22
NI200900154A (es) 2010-03-25
EA016896B1 (ru) 2012-08-30
SG158830A1 (en) 2010-02-26
JO2812B1 (en) 2014-09-15
AU2009203071A1 (en) 2010-02-25
WO2010015747A1 (fr) 2010-02-11
PT2151430E (pt) 2011-08-25
JP2010037345A (ja) 2010-02-18
HK1141005A1 (en) 2010-10-29
JP5047240B2 (ja) 2012-10-10
UY32014A (es) 2010-01-29
KR20100017070A (ko) 2010-02-16
CA2674770C (fr) 2012-04-17
CY1111873T1 (el) 2015-11-04
ME00929B (me) 2012-06-20
CN101643432A (zh) 2010-02-10
ES2371047T3 (es) 2011-12-26
AP3196A (en) 2015-03-31
PL2151430T3 (pl) 2011-12-30
UA102816C2 (ru) 2013-08-27

Similar Documents

Publication Publication Date Title
HRP20110712T1 (hr) Novi postupak za dobivanje kristalnog oblika agomelatina
Zhang et al. Synthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives
TW200736197A (en) New crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
CN103435509B (zh) 一种n-酰基酸性氨基酸或其盐的制备方法及其应用
CO6120149A1 (es) Nueva forma cristalina vi de la agomelatina su procedimiento de preparacion y las composiciones farmaceuticas que la contienen
RS52423B (en) THE NEW CRYSTAL FORM OF AGOMELATIN, THE PROCEDURE FOR THE PRODUCTION OF IT AND THE PHARMACEUTICAL MIXTURES CONTAINING IT
AR088296A1 (es) Citramida de rasagilina, proceso de preparación y composicion farmaceutica
CN102965669B (zh) 水溶性高温缓蚀剂的制备方法
CN102500087A (zh) 直接充当水成膜泡沫灭火剂主剂的全氟己烷表面活性剂的制备方法
Häkkinen et al. Effect of composition and water content on physicochemical properties of choline chloride-boric acid low-melting mixtures
HRP20100217T1 (hr) POLIMORFI tert-BUTILNOG ESTERA ATORVASTATINA I NJIHOVA UPOTREBA KAO MEĐUPRODUKATA U DOBIVANJU ATORVASTATINA
MD20120130A2 (en) Delta crystalline form of the L-arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
CN104628743B (zh) 头孢硫脒化合物的新晶型及其结晶制备方法
TN2011000598A1 (en) Process for the preparation of a compositon comprising meso-tartaric acid
CN104630783B (zh) 含Cr油管用酸化缓蚀剂及其制备方法
PE20070019A1 (es) Forma polimorfica de dexcetoprofeno trometamol, su preparacion y composiciones que lo contienen
CN102766065B (zh) 一种氟碳表面活性剂n-二羟乙基全氟辛酰胺的合成方法
HRP20170394T1 (hr) Postupak za sintezu 3,4-dimetoksibiciklo[4.2.0]okta-1,3,5-trien-7-karbonitrila i uporaba za sintezu ivabadina i njegovih adicijskih soli s farmacetuski prihvatljivom kiselinom
Wang et al. Synthesis and surface activities of novel monofluoroalkyl phosphate surfactants
CN107746672B (zh) 一种电力设备专用的复合涂层材料
WO2012076736A1 (es) Fenucil deuterado y derivados, procedimiento para su preparación y usos de los mismos
CN107245734A (zh) 一种无氰镀银用电镀液
BR0107898A (pt) Processo para a preparação do composto, composto, composição farmacêutica, uso dos compostos, e, processo para a preparação dos compostos
CN107384547A (zh) 一种汽车零件高硬度防锈切削液
CN103588755A (zh) Neratinib的制备方法